ROTHBLATT MARTINE A Insider Trading Activity

Average Profitability
20.16%
Insider Buys Quantity
30
Insider Buys Sum
$13.65M
Insider Sells Quantity
1099
Insider Sells Sum
$1.05B

Insider Activity of ROTHBLATT MARTINE A

According to the SEC Form 4 filings, ROTHBLATT MARTINE A, being in a position of

  1. Chairperson & CEO at United Therapeutics Corporation,
    оver the last 12 months, has bought 1500 shares for $863,947, and sold 1855302 shares for $993.82M,
    over all time since 2003-06-12, has bought 231257 shares for $14.52M, and sold 9718713 shares for $2.11B.

Biography of ROTHBLATT MARTINE A

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $863,94710
Sells
 $993,824,523225100

Comparison of Insiders on Amount of Buys and Sells

2026-11-02SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0223%
$596.22$5.66M+0.85%
2026-10-30SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0224%
$600.09$5.7M+<0.01%
2026-10-29SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0222%
$594.78$5.65M+0.87%
2026-10-29SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
2,720
0.0064%
$592.49$1.61M
2026-10-28SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0221%
$585.49$5.56M+1.87%
2026-10-27SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.022%
$587.73$5.58M+0.83%
2026-10-26SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0221%
$588.64$5.59M+0.34%
2026-10-23SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0221%
$582.76$5.54M+1.03%
2026-10-22SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0221%
$583.38$5.54M+1.44%
2026-10-21SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.022%
$560.07$5.32M+5.21%
2026-10-20SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0221%
$553.87$5.26M+6.89%
2026-10-19SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0222%
$543.32$5.16M+8.85%
2026-10-16SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0222%
$534.66$5.08M+10.55%
2026-10-15SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0224%
$546.65$5.19M+8.49%
2026-10-14SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0224%
$539.99$5.13M+8.7%
2026-10-13SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0225%
$545.52$5.18M+7.93%
2026-10-12SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0223%
$550.70$5.23M+6.46%
2026-10-09SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0221%
$544.94$5.18M+6.49%
2026-10-08SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0224%
$534.31$5.08M+7.76%
2026-10-07SaleUnited Therapeutics Corporation
UTHR
Chairperson & CEO
9,500
0.0225%
$548.95$5.22M+3.39%
Total: 1397
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.